Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis

JACC: Cardiovascular Interventions

Volumn 4, Issue 2, 2011, Pages 149-154

  Habara, Seiji ^a   Mitsudo, Kazuaki ^a   Kadota, Kazushige ^a   Goto, Tsuyoshi ^a   Fujii, Satoki ^a   Yamamoto, Hiroyuki ^a   Katoh, Harumi ^a   Oka, Naoki ^a   Fuku, Yasushi ^a   Hosogi, Shingo ^a   Hirono, Akitoshi ^a   Maruo, Takeshi ^a   Tanaka, Hiroyuki ^a   Shigemoto, Yoshikazu ^a   Hasegawa, Daiji ^a   Tasaka, Hiroshi ^a   Kusunose, Mana ^a   Otsuru, Suguru ^a   Okamoto, Yoji ^a   Saito, Naoki ^a   Tsujimoto, Yuki ^a   Eguchi, Haruki ^a   Miyake, Koshi ^a   Yoshino, Mitsuru ^a   more..

^a KURASHIKI CENTRAL HOSPITAL   (Japan)

Author keywords

drug eluting balloon; in stent restenosis (ISR); sirolimus eluting stent (SES) restenosis

Indexed keywords

PACLITAXEL; RAPAMYCIN;

AGED; ANGIOPLASTY; ARTICLE; BALLOON CATHETER; CARDIAC PATIENT; CLINICAL ARTICLE; DRUG ELUTING STENT; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; INCIDENCE; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SINGLE BLIND PROCEDURE; SURVIVAL; THERAPY;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DISEASE-FREE SURVIVAL; DRUG-ELUTING STENTS; FEMALE; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PACLITAXEL; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SINGLE-BLIND METHOD; SIROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79951990739     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2010.10.012     Document Type: Article

References (23)

1. D.R. Holmes Jr., M.B. Leon, and J.W. Moses Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis Circulation 109 2004 634 640 (Pubitemid 38198871)
2. J.W. Moses, M.B. Leon, and J.J. Popma Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323 (Pubitemid 37186209)
3. J. Cosgrave, G. Melzi, and S. Corbett Repeated drug-eluting stent implantation for drug-eluting stent restenosis: the same or a different stent Am Heart J 153 2007 354 359 (Pubitemid 46328767)
4. S. Garg, K. Smith, and R. Torguson Treatment of drug-eluting stent restenosis with the same versus different drug-eluting stent Catheter Cardiovasc Interv 70 2007 9 14 (Pubitemid 47039112)
5. S.S. Lee, M.J. Price, and G.B. Wong Early- and medium-term outcomes after paclitaxel-eluting stent implantation for sirolimus-eluting stent failure Am J Cardiol 98 2006 1345 1348 (Pubitemid 44666642)
6. G.J. Mishkel, A.L. Moore, S. Markwell, M.C. Shelton, and M.E. Shelton Long-term outcomes after management of restenosis or thrombosis of drug-eluting stents J Am Coll Cardiol 49 2007 181 184 (Pubitemid 46054395)
7. B. Scheller, C. Hehrlein, and W. Bocksch Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter N Engl J Med 355 2006 2113 2124 (Pubitemid 44749319)
8. B. Scheller, C. Hehrlein, and W. Bocksch Two-year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter Clin Res Cardiol 97 2008 773 781
9. R. Mehran, G. Dangas, and A.S. Abizaid Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome Circulation 100 1999 1872 1878 (Pubitemid 29511140)
10. D.E. Cutlip, S. Windecker, and R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
11. M. Unverdorben, C. Vallbracht, and B. Cremers Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis Circulation 119 2009 2986 2994
12. J. Cosgrave, G. Melzi, and G.G. Biondi-Zoccai Drug-eluting stent restenosis: the pattern predicts the outcome J Am Coll Cardiol 47 2006 2399 2404 (Pubitemid 43866381)
13. C. Whan-Lee, S.H. Kim, and J. Suh Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents Catheter Cardiovasc Interv 71 2008 594 598 (Pubitemid 351550393)
14. D.H. Steinberg, M.A. Gaglia Jr., and T.L. Pinto-Slottow Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents Am J Cardiol 103 2009 491 495
15. K. Fujii, G.S. Mintz, and Y. Kobayashi Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis Circulation 109 2004 1085 1088 (Pubitemid 38332610)
16. I. Iakovou, G. Stankovic, and M. Montorfano Is overdilatation of 3.0 mm sirolimus-eluting stent associated with a higher restenosis rate? Catheter Cardiovasc Interv 64 2005 129 133 (Pubitemid 40189177)
17. G. Sianos, S. Hofma, and J.M. Ligthart Stent fracture and restenosis in the drug-eluting stent era Catheter Cardiovasc Interv 61 2004 111 116 (Pubitemid 38036800)
18. H. Takebayashi, G.S. Mintz, and S.G. Carlier Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation Circulation 110 2004 3430 3434 (Pubitemid 39602221)
19. J.R. Nebeker, R. Virmani, and C.L. Bennett Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project J Am Coll Cardiol 47 2006 175 181 (Pubitemid 43005183)
20. R. Virmani, G. Guagliumi, and A. Farb Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109 2004 701 705 (Pubitemid 38222887)
21. M. Joner, A.V. Finn, and A. Farb Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 2006 193 202 (Pubitemid 43929240)
22. A. Kastrati, A. Dibra, and J. Mehilli Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents Circulation 113 2006 2293 2300 (Pubitemid 43947975)
23. J. Mehilli, R.A. Byrne, and K. Tiroch Randomized trial of paclitaxel-versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study J Am Coll Cardiol 55 2010 2710 2716